SOUTH SAN FRANCISCO, Calif.– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Vanderbilt University Medical Center (VUMC) to supply synthetic genes and antibodies for the development of therapies for COVID-19. In addition, Twist Biopharma, a division […]

Genovis’ Nomination Committee proposes new election of Torben Jørgensen to serve on the Board of Directors and as Chairman of the Board at the Annual General Meeting on May 5.   Torben Jørgensen was born in 1952 and is currently Chairman of the Board of Biotage AB and Atlas Antibodies AB. He also serves on the […]

LUND, Sweden–Genovis enzymes are used as platform methods in analytical workflows using mass spectrometry within the biopharma industry. Immobilized SialEXO benefits mass spectrometry but will significantly impact analytical workflows using capillary electrophoresis (CE). Charge variants of proteins are often analyzed using CE and the technology is well established for protein analysis and quality control. From our […]

MINNEAPOLIS – Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, has been validating a growing number of immunohistochemistry (IHC) antibodies using the Advanced Cell Diagnosticsâ„¢-branded RNAscope in situ hybridization (ISH) platform to leverage its transcriptomics approach to providing high quality, validated IHC […]